APA (7th ed.) Citation

Luyan Liu, Yi Wu, Kaiyan Ye, Kaiyan Ye, Meichun Cai, Meichun Cai, . . . Jieyi Wang. (2022). Antibody-Targeted TNFRSF Activation for Cancer Immunotherapy: The Role of FcγRIIB Cross-Linking. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Luyan Liu, Yi Wu, Kaiyan Ye, Kaiyan Ye, Meichun Cai, Meichun Cai, Guanglei Zhuang, Guanglei Zhuang, and Jieyi Wang. Antibody-Targeted TNFRSF Activation for Cancer Immunotherapy: The Role of FcγRIIB Cross-Linking. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Luyan Liu, et al. Antibody-Targeted TNFRSF Activation for Cancer Immunotherapy: The Role of FcγRIIB Cross-Linking. Frontiers Media S.A., 2022.